273 related articles for article (PubMed ID: 10732883)
1. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).
Kjøller-Hansen L; Steffensen R; Grande P
J Am Coll Cardiol; 2000 Mar; 35(4):881-8. PubMed ID: 10732883
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular function and no clinical heart failure.
Kjøller-Hansen L; Steffensen R; Grande P
J Am Coll Cardiol; 2001 Apr; 37(5):1214-20. PubMed ID: 11300425
[TBL] [Abstract][Full Text] [Related]
3. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
Kjøller-Hansen L; Steffensen R; Grande P
Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
[TBL] [Abstract][Full Text] [Related]
4. The Angiotensin Converting Enzyme Inhibition Post Revascularization Study (APRES). Effects of ramipril in patients with reduced left ventricular function. Rationale, design, methods, baseline characteristics and first-year experience.
Kjøller-Hansen L; Steffensen R; Grande P
Scand Cardiovasc J; 1998; 32(4):225-32. PubMed ID: 9802141
[TBL] [Abstract][Full Text] [Related]
5. Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).
Borghi C; Ambrosioni E; Novo S; Vinereanu D; Ambrosio G;
Clin Cardiol; 2012; 35(7):416-23. PubMed ID: 22707187
[TBL] [Abstract][Full Text] [Related]
6. Effect of ramipril on postrevascularization prevalence of angina and quality of life.
Kjøller-Hansen L; Steffensen R; Grande P
Int J Cardiol; 2004 Jun; 95(2-3):159-65. PubMed ID: 15193814
[TBL] [Abstract][Full Text] [Related]
7. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.
; Yusuf S; Sleight P; Pogue J; Bosch J; Davies R; Dagenais G
N Engl J Med; 2000 Jan; 342(3):145-53. PubMed ID: 10639539
[TBL] [Abstract][Full Text] [Related]
8. Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials.
Young JB
Cardiovasc Drugs Ther; 1995 Feb; 9(1):89-102. PubMed ID: 7786840
[TBL] [Abstract][Full Text] [Related]
9. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
[TBL] [Abstract][Full Text] [Related]
10. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
[TBL] [Abstract][Full Text] [Related]
11. [Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].
Rodríguez JA; Godoy I; Castro P; Quintana JC; Chávez E; Yovanovich J; Corbalán R; Chávez A
Rev Med Chil; 1997 Jun; 125(6):643-52. PubMed ID: 9515282
[TBL] [Abstract][Full Text] [Related]
12. Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study.
Dagenais GR; Yusuf S; Bourassa MG; Yi Q; Bosch J; Lonn EM; Kouz S; Grover J;
Circulation; 2001 Jul; 104(5):522-6. PubMed ID: 11479247
[TBL] [Abstract][Full Text] [Related]
13. Treatment with ramipril improves systolic function even in patients with mild systolic dysfunction and symptoms of heart failure after acute myocardial infarction.
Kongstad-Rasmussen O; Blomstrand P; Broqvist M; Dahlström U; Wranne B
Clin Cardiol; 1998 Nov; 21(11):807-11. PubMed ID: 9825192
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting-enzyme inhibition in stable coronary artery disease.
Braunwald E; Domanski MJ; Fowler SE; Geller NL; Gersh BJ; Hsia J; Pfeffer MA; Rice MM; Rosenberg YD; Rouleau JL;
N Engl J Med; 2004 Nov; 351(20):2058-68. PubMed ID: 15531767
[TBL] [Abstract][Full Text] [Related]
15. Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study.
Solomon SD; Glynn RJ; Greaves S; Ajani U; Rouleau JL; Menapace F; Arnold JM; Hennekens C; Pfeffer MA
Ann Intern Med; 2001 Mar; 134(6):451-8. PubMed ID: 11255520
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
17. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
[TBL] [Abstract][Full Text] [Related]
18. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study.
Arnold JM; Yusuf S; Young J; Mathew J; Johnstone D; Avezum A; Lonn E; Pogue J; Bosch J;
Circulation; 2003 Mar; 107(9):1284-90. PubMed ID: 12628949
[TBL] [Abstract][Full Text] [Related]
19. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study. Acute Infarction Ramipril Efficacy.
Hall AS; Murray GD; Ball SG
Lancet; 1997 May; 349(9064):1493-7. PubMed ID: 9167457
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
